A Randomized, Double-Blind, Parallel-Group Phase III Trial Investigating the Glycemic Efficacy and Safety Profile of Fixed-Dose Combination Dapagliflozin and Linagliptin Over Linagliptin Monotherapy in Patients with Inadequately Controlled Type 2 Diabetes with Metformin
一项随机、双盲、平行组 III 期临床试验,旨在研究达格列净和利格列汀固定剂量复方制剂与利格列汀单药治疗相比,在二甲双胍治疗血糖控制不佳的 2 型糖尿病患者中的降糖疗效和安全性。
期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-023-01504-3
Jain, Aditi; Vispute, Abhay; Dange, Amol; Naskar, Arindam; Mondal, Asish; Vivekanand, B; Sharma, Balram; Varade, Deepak; Shukla, Dhaiwat; Bhatia, Girish; Chaudhari, Harshal; Ram Babu, K; Gavali, Onkar; Sorate, Sanket; Bhanushali, Shaishav; Kothari, Vaibhav; Khandelwal, Vipul; Sharma, Akhilesh; Pawar, Roshan; Mayabhate, Mayur; Shahavi, Vinayaka; Rajput, Aashishsingh; Jaiswal, Mukesh